Related Experiment Videos
Direct cardiac compression for cardiogenic shock with the CardioSupport system
1Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA. mw365@columbia.edu
The Annals of Thoracic Surgery
|March 27, 2001
Summary
Direct cardiac compression via the CardioSupport system offers a novel, sutureless treatment for cardiogenic shock. This innovative approach avoids blood contact, potentially reducing complications and restoring near-normal heart function in preclinical studies.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Cardiogenic shock requires immediate intervention to maintain cardiac output.
- Current treatments carry risks of thromboembolic and immunologic complications due to blood surface interfaces.
Purpose of the Study:
- To introduce and evaluate the CardioSupport system, a novel epicardial direct cardiac compression device.
- To assess the potential of this device as an alternative treatment for cardiogenic shock.
Main Methods:
- The Cardio Technologies device delivers synchronized biventricular cardiac compression.
- Placement is achieved via thoracotomy, with the device remaining on the heart without sutures.
Main Results:
- Preclinical studies demonstrated successful restoration of cardiac function in heart failure models.
- The device showed potential for rapid placement and technical ease.
Conclusions:
- Epicardial direct cardiac compression offers a promising, sutureless alternative for cardiogenic shock.
- The CardioSupport system is being prepared for clinical trials, suggesting potential for improved patient outcomes.